Folgen
YUXIN HOU
YUXIN HOU
The University of Hong Kong
Keine bestätigte E-Mail-Adresse
Titel
Zitiert von
Zitiert von
Jahr
Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory …
H Chu, JFW Chan, TTT Yuen, H Shuai, S Yuan, Y Wang, B Hu, CCY Yip, ...
The Lancet Microbe 1 (1), e14-e23, 2020
8952020
Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19
H Chu, JFW Chan, Y Wang, TTT Yuen, Y Chai, Y Hou, H Shuai, D Yang, ...
Clinical Infectious Diseases 71 (6), 1400-1409, 2020
7662020
Attenuated replication and pathogenicity of SARS-CoV-2 B. 1.1. 529 Omicron
H Shuai, JFW Chan, B Hu, Y Chai, TTT Yuen, F Yin, X Huang, C Yoon, ...
Nature 603 (7902), 693-699, 2022
6102022
Attenuated interferon and proinflammatory response in SARS-CoV-2–infected human dendritic cells is associated with viral antagonism of STAT1 phosphorylation
D Yang, H Chu, Y Hou, Y Chai, H Shuai, ACY Lee, X Zhang, Y Wang, ...
The Journal of infectious diseases 222 (5), 734-745, 2020
2062020
Middle East respiratory syndrome coronavirus and bat coronavirus HKU9 both can utilize GRP78 for attachment onto host cells
H Chu, CM Chan, X Zhang, Y Wang, S Yuan, J Zhou, RKH Au-Yeung, ...
Journal of Biological Chemistry 293 (30), 11709-11726, 2018
1932018
Emerging SARS-CoV-2 variants expand species tropism to murines
H Shuai, JFW Chan, TTT Yuen, C Yoon, JC Hu, L Wen, B Hu, D Yang, ...
EBioMedicine 73, 2021
1522021
Host and viral determinants for efficient SARS-CoV-2 infection of the human lung
H Chu, B Hu, X Huang, Y Chai, D Zhou, Y Wang, H Shuai, D Yang, Y Hou, ...
Nature communications 12 (1), 134, 2021
1492021
An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron
BX Quan, H Shuai, AJ Xia, Y Hou, R Zeng, XL Liu, GF Lin, JX Qiao, WP Li, ...
Nature Microbiology 7 (5), 716-725, 2022
832022
Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severity
H Chu, H Shuai, Y Hou, X Zhang, L Wen, X Huang, B Hu, D Yang, ...
Science advances 7 (25), eabf8577, 2021
822021
Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA. 1 and BA. 2
B Hu, JFW Chan, H Liu, Y Liu, Y Chai, J Shi, H Shuai, Y Hou, X Huang, ...
Emerging Microbes & Infections 11 (1), 2275-2287, 2022
732022
Competing endogenous RNA network profiling reveals novel host dependency factors required for MERS-CoV propagation
X Zhang, H Chu, L Wen, H Shuai, D Yang, Y Wang, Y Hou, Z Zhu, S Yuan, ...
Emerging microbes & infections 9 (1), 733-746, 2020
652020
Coronaviruses exploit a host cysteine-aspartic protease for replication
H Chu, Y Hou, D Yang, L Wen, H Shuai, C Yoon, J Shi, Y Chai, TTT Yuen, ...
Nature 609 (7928), 785-792, 2022
602022
Human coronavirus dependency on host heat shock protein 90 reveals an antiviral target
C Li, H Chu, X Liu, MC Chiu, X Zhao, D Wang, Y Wei, Y Hou, H Shuai, ...
Emerging Microbes & Infections 9 (1), 2663-2672, 2020
552020
Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: Implications for treatment with IFN-β and IFN inducer
H Shuai, H Chu, Y Hou, D Yang, Y Wang, B Hu, X Huang, X Zhang, ...
Journal of Infection 81 (4), e1-e10, 2020
532020
SARS-CoV-2 induces a more robust innate immune response and replicates less efficiently than SARS-CoV in the human intestines: an ex vivo study with implications on …
H Chu, JFW Chan, Y Wang, TTT Yuen, Y Chai, H Shuai, D Yang, B Hu, ...
Cellular and molecular gastroenterology and hepatology 11 (3), 771-781, 2021
522021
A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variants
C Huang, H Shuai, J Qiao, Y Hou, R Zeng, A Xia, L Xie, Z Fang, Y Li, ...
Signal Transduction and Targeted Therapy 8 (1), 128, 2023
512023
Bacillus Calmette-Guérin–induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice
BZ Zhang, H Shuai, HR Gong, JC Hu, B Yan, TTT Yuen, YF Hu, C Yoon, ...
JCI insight 7 (11), 2022
512022
Virological features and pathogenicity of SARS-CoV-2 Omicron BA. 2
JFW Chan, B Hu, Y Chai, H Shuai, H Liu, J Shi, Y Liu, C Yoon, J Zhang, ...
Cell Reports Medicine 3 (9), 2022
362022
The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA. 1, BA. 2, and BA. 5
H Shuai, JFW Chan, B Hu, Y Chai, C Yoon, H Liu, Y Liu, J Shi, T Zhu, ...
EBioMedicine 95, 2023
342023
A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivo
JFW Chan, YJ Oh, S Yuan, H Chu, ML Yeung, D Canena, CCS Chan, ...
Cell Reports Medicine 3 (10), 2022
322022
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20